Replies to post #154615 on Biotech Values

[ronpopeil]

You would think the EMEA would approve since the FDA approved. I completely understand that it's not a guarantee but i see the FDA as being stricter than the EMEA and since this is a terrible disease, they should get approval. The stock seems very undervalued

[ronpopeil]

AEGR looking strong. Mentioned in Adam's 2013 prediction news piece (#13)

13. Strong 2013 drug launches: NPS Pharma (NPSP_) (Gattex), Medivation (MDVN) (Xtandi), Aegerion Pharma (AEGR_) (Juxtapid), Roche (RHHBY) (T-DM1), Biogen Idec (BIIB_) (BG-12), Onyx Pharma (Kyprolis).